regn5458
regeneron pharmaceuticals
['mmsm', 'regn5458']
congress | #eha2022 | presents phase 1 results of regn5458 in rr #myeloma. data suggest acceptable safety profile and promising efficacy in heavily pre-treated patients. no gr3 icans or 3 crs, two dlts. orr 75%. #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma